{
    "id": 26625,
    "fullName": "TNFRSF17 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TNFRSF17 positive indicates the presence of the TNFRSF17 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 608,
        "geneSymbol": "TNFRSF17",
        "terms": [
            "TNFRSF17",
            "BCM",
            "BCMA",
            "CD269",
            "TNFRSF13A"
        ]
    },
    "variant": "positive",
    "createDate": "05/26/2017",
    "updateDate": "05/26/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11019,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, multiple myeloma cells were sensitive to treatment with KITE-585 (Anti-TNFRSF17 CAR T cells), demonstrating cell death in culture and delayed disease progression in cell line xenograft models (AACR Meeting, 2017, abstract nr 4979).",
            "molecularProfile": {
                "id": 27884,
                "profileName": "TNFRSF17 positive"
            },
            "therapy": {
                "id": 5795,
                "therapyName": "KITE-585",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9007,
                    "pubMedId": null,
                    "title": "Development of KITE-585: a fully human BCMA CAR T-cell therapy for the treatment of multiple myeloma",
                    "url": "http://www.aacr.org/Documents/AACR2017_Proceedings.pdf"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12596,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, bb2121 treatment resulted in an overall response of 89% (16/18) in multiple myeloma patients (ASH 59th Annual Meeting and Exposition, Dec 2017, Abstract 740; NCT02658929).",
            "molecularProfile": {
                "id": 27884,
                "profileName": "TNFRSF17 positive"
            },
            "therapy": {
                "id": 5278,
                "therapyName": "bb2121",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 10469,
                    "pubMedId": null,
                    "title": "Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy",
                    "url": "https://ash.confex.com/ash/2017/webprogram/Paper107984.html"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12094,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, P-BCMA-101 CAR-T cells eliminated tumor cells and improved survival in cell line xenograft models of multiple myeloma (Blood 2016 128 (22):2127).",
            "molecularProfile": {
                "id": 27884,
                "profileName": "TNFRSF17 positive"
            },
            "therapy": {
                "id": 6280,
                "therapyName": "P-BCMA-101 CAR-T cells",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10031,
                    "pubMedId": null,
                    "title": "A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma",
                    "url": "http://www.bloodjournal.org/content/128/22/2127?sso-checked=true"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19586,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, multiple myeloma cell lines expressing either low or high levels of TNFRSF17 demonstrated sensitivity to MEDI2228 treatment in culture (Blood (2017) 130 (Supplement 1): 3153).",
            "molecularProfile": {
                "id": 27884,
                "profileName": "TNFRSF17 positive"
            },
            "therapy": {
                "id": 9088,
                "therapyName": "MEDI2228",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17190,
                    "pubMedId": null,
                    "title": "Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma",
                    "url": "https://ashpublications.org/blood/article/130/Supplement%201/3153/114444"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27884,
            "profileName": "TNFRSF17 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}